Copper 64–labeled daratumumab as a PET/CT imaging tracer for multiple myeloma

As a growing number of patients with multiple myeloma (MM) respond to upfront therapies while eventually relapsing in a time frame that is often unpredictable, attention has increasingly focused on developing novel diagnostic criteria to also account for disease dissemination. Positron emission tomo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: Caserta, Enrico, Chea, Junie, Minnix, Megan, Viola, Domenico, Vonderfecht, Steven, Yazaki, Paul, Crow, Desiree, Khalife, Jihane, Sanchez, James F., Palmer, Joycelynne M., Hui, Susanta, Carlesso, Nadia, Keats, Jonathan, Kim, Young, Buettner, Ralf, Marcucci, Guido, Rosen, Steven, Shively, John, Colcher, David, Krishnan, Amrita, Pichiorri, Flavia
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2018
Materias:
Immunobiology and Immunotherapy
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5814935/
https://ncbi.nlm.nih.gov/pubmed/29301755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-09-807263
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares